Fact Sheet for Healthcare Providers: RealStar ® SARS-CoV-2 RT-PCR Kit U.S. – altona Diagnostics GmbH

Source: U.S. Food and Drug Administration (FDA). Published: 4/22/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the RealStar ® SARS-CoV-2 RT-PCR Kit U.S., which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. The RealStar® SARS-CoV-2 RT-PCR Kit U.S. is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)

https://disasterinfo.nlm.nih.gov/search/id:21935

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 22, 2020 Category: International Medicine & Public Health Source Type: news